Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer
Chengheng Liao(Southwestern Medical Center), Qing Zhang(Southwestern Medical Center), Huanghe Yang(Duke University), Lianxin Hu(Chinese Academy of Sciences), Mamoru Takada(University of North Carolina at Chapel Hill), Jason W. Locasale(Duke University), Laura E. Herring(University of North Carolina at Chapel Hill), Charles M. Perou(University of North Carolina at Chapel Hill), Jin Zhou(The University of Texas Southwestern Medical Center), Einārs Loža(Latvijas Organiskās Sintēzes Institūts), Travis Ptacek(University of North Carolina at Chapel Hill), Yan Peng(The University of Texas Southwestern Medical Center), Cheng Fan(University of North Carolina at Chapel Hill), Yang Zhang(Duke University), Victor G. Andrianov(Latvijas Organiskās Sintēzes Institūts), Jeremy M. Simon(Harvard University), Juan Liu(Shandong University of Traditional Chinese Medicine), Giada Zurlo(University of North Carolina at Chapel Hill)
Cited by 68
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k